Hypothalamic ventricular administration of EPO in aged obese mice decreased food intake and obesity, improved metabolic function, and reversed impairments in glucose tolerance and insulin sensitivity without increasing hematocrit [67]. The gene discussed is EPO; the disease is obesity disorder.